EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $252,000 | +20.6% | 20,800 | -2.1% | 0.00% | – |
| Q3 2016 | $209,000 | +8.3% | 21,244 | +12.5% | 0.00% | – |
| Q2 2016 | $193,000 | -16.1% | 18,879 | -0.3% | 0.00% | – |
| Q1 2016 | $230,000 | +21.7% | 18,937 | +60.9% | 0.00% | – |
| Q4 2015 | $189,000 | -15.6% | 11,768 | -32.5% | 0.00% | – |
| Q3 2015 | $224,000 | -47.5% | 17,435 | -2.0% | 0.00% | – |
| Q2 2015 | $427,000 | -55.1% | 17,784 | -64.9% | 0.00% | -100.0% |
| Q1 2015 | $952,000 | +29.3% | 50,679 | +29.9% | 0.00% | 0.0% |
| Q4 2014 | $736,000 | +315.8% | 39,016 | +499.1% | 0.00% | – |
| Q3 2014 | $177,000 | -98.6% | 6,512 | -98.4% | 0.00% | -100.0% |
| Q2 2014 | $12,933,000 | +41.9% | 415,616 | +3.9% | 0.01% | +33.3% |
| Q1 2014 | $9,111,000 | +14836.1% | 400,155 | +13655.8% | 0.01% | – |
| Q4 2013 | $61,000 | -97.5% | 2,909 | -95.2% | 0.00% | -100.0% |
| Q3 2013 | $2,402,000 | +2940.5% | 60,045 | +2030.0% | 0.00% | – |
| Q2 2013 | $79,000 | – | 2,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |